Translational Medicine: Pharmaceutical Cancer (MRes) - closed until 2013
View by page | View all content (for printing)
Year of entry: 2012
Degree awarded: Master of Research
Duration: 12 months FT
An honours degree (minimum 2:1) in the biomedical sciences. International candidates must have obtained the equivalent of a 2:1 in a related degree from a reputed University.
Candidates on the undergraduate medical programme must have satisfactorily completed years 1-3 of the MBChB. For St Andrews students, this includes their 3 year degree programme and the following year spent in Manchester (year 3 of the Manchester programme).
Students with evidence of previous advanced study, research or professional experience may be accepted by the University as qualification for entry.
Course fees: For entry in the academic year beginning September 2012, the tuition fees are as follows:
-
MRes (full-time)
UK/EU students (per annum): £6,800
International students (per annum): £17,800
The fees quoted above will be fully inclusive for the course tuition, administration and computational costs during your studies.
All fees for entry will be subject to yearly review and incremental rises per annum are also likely over the duration of courses lasting more than a year for UK/EU students (fees are typically fixed for International students, for the course duration at the year of entry). For general fees information please visit: postgraduate fees . Always contact the department if you are unsure which fee applies to your qualification award and method of attendance.
Bursaries of £1000 are available to students for 2011 entry. These bursaries will be awarded to the five best applicants based on performance at interview and academic merit.
The decision on award of bursaries will be made after the last round of interviews after the 31st July closing date.
Number of places/applicants: 20 places.
Contact email: naomi.wells@manchester.ac.uk
Contact telephone: +44 (0)161 275 1367
Note that due to unanticipated circumstances, Translational Medicine: Pharmaceutical Cancer MRes will not be accepting entrants for 2012 intake. Interested individuals may wish to apply instead for the related Masters of Research in Translational Medicine, Interdisciplinary Molecular Medicine:
Course options
| Full-time | Part-time | Full-time distance learning | Part-time distance learning | |
|---|---|---|---|---|
| MRes | Y | N | N | N |
